Dr Christopher Chan
Clinical (Lecturer)
The Sir Peter MacCallum Department of Oncology
13 Scholarly works
0 Projects
HIGHLIGHTS
2016
Book Chapter
Inflammation and Cancer
DOI: 10.1016/B978-0-12-374279-7.17002-X2014
Journal article
Cutting edge: DNAX accessory molecule 1-deficient CD8 T cells display immunological synapse defects that impair antitumor immunity
DOI: 10.4049/jimmunol.13021972014
Journal article
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
DOI: 10.1038/ni.28502013
Journal article
Erratum: Recognition of the nonclassical MHC class i molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells (Nature Immunology (2012) 13 (1171-1177)
DOI: 10.1038/ni0413-413b2013
Journal article
Poker face no more: Cancer recurrence reveals its hand
DOI: 10.1038/nm.34102013
Journal article
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence
DOI: 10.1158/2159-8290.CD-12-04042012
Journal article
Recognition of the nonclassical MHC class i molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells
DOI: 10.1038/ni.2468
RECENT SCHOLARLY WORKS
2012
Journal article
An immunosurveillance mechanism controls cancer cell ploidy
DOI: 10.1126/science.12249222012
Journal article
Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer
DOI: 10.1016/j.coi.2012.01.0092010
Journal article
The interactions of multiple cytokines control NK cell maturation
DOI: 10.4049/jimmunol.0903354